These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 15061965)
21. Effects of hypoxia-inducible factor-1alpha expression and C4d deposition in implantation biopsies on renal allograft. Kim DJ; Lee S; Kim SJ; Park SG; Kim JS; Hyun SJ; Song YS; Nam ES Transplant Proc; 2008 Sep; 40(7):2145-6. PubMed ID: 18790175 [TBL] [Abstract][Full Text] [Related]
22. Correlation between endothelin expression in early post-transplant biopsy specimens and long-term allograft function in living-related renal transplantation. Takeda M; Ishida T; Ishimura T; Fujisawa M Clin Transplant; 2006; 20(1):26-9. PubMed ID: 16556149 [TBL] [Abstract][Full Text] [Related]
23. SDF-1 expression is elevated in chronic human renal allograft rejection. Hoffmann U; Banas B; Krüger B; Banas M; Bergler T; Böger C; Kammerl M; Obed A; Rümmele P; Segerer S; Riegger GA; Krämer BK Clin Transplant; 2006; 20(6):712-8. PubMed ID: 17100720 [TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of RANTES and MIP-1 alpha in acute rejection episode in kidney transplantation]. Shi BB; Wang HJ; Ji ZG; Wang JT; Li HZ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):70-2. PubMed ID: 15052779 [TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor expression in human renal allograft biopsies: an immunohistochemical study. Sis B; Sarioglu S; Celik A; Zeybel M; Soylu A; Bora S Transpl Immunol; 2004 Nov; 13(3):229-32. PubMed ID: 15381206 [TBL] [Abstract][Full Text] [Related]
27. Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal allograft. Wagrowska-Danilewicz M; Danilewicz M Pol J Pathol; 2008; 59(4):189-94. PubMed ID: 19391484 [TBL] [Abstract][Full Text] [Related]
28. Expression of carcinoembryonic antigen-related cell adhesion molecule 1 in acute rejection of human renal allografts. Sager HB; Ergun S; Hartmann A; Hoffmann U; Krämer BK; Mihatsch MJ; Weil J Transplant Proc; 2009 Jun; 41(5):1536-40. PubMed ID: 19545674 [TBL] [Abstract][Full Text] [Related]
29. Expression of the chemokine receptor CCR1 in human renal allografts. Mayer V; Hudkins KL; Heller F; Schmid H; Kretzler M; Brandt U; Anders HJ; Regele H; Nelson PJ; Alpers CE; Schlöndorff D; Segerer S Nephrol Dial Transplant; 2007 Jun; 22(6):1720-9. PubMed ID: 17298994 [TBL] [Abstract][Full Text] [Related]
30. Up-regulation of cyclooxygenase-2 during acute human renal allograft rejection. Rangel EB; Moura LA; Franco MF; Pacheco-Silva A Clin Transplant; 2005 Aug; 19(4):543-50. PubMed ID: 16008603 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of cytotoxic T-lymphocytes and CD40 in biopsies with early renal allograft rejection. Mengel M; Mueller I; Behrend M; von Wasielewski R; Radermacher J; Schwarz A; Haller H; Kreipe H Transpl Int; 2004 Jul; 17(6):293-300. PubMed ID: 15221125 [TBL] [Abstract][Full Text] [Related]
33. The presence of B-cell nodules does not necessarily portend a less favorable outcome to therapy in patients with acute cellular rejection of a renal allograft. Doria C; di Francesco F; Ramirez CB; Frank A; Iaria M; Francos G; Marino IR; Farber JL Transplant Proc; 2006 Dec; 38(10):3441-4. PubMed ID: 17175297 [TBL] [Abstract][Full Text] [Related]
34. Comparative study for the detection of peritubular capillary C4d deposition in human renal allografts using different methodologies. Nadasdy GM; Bott C; Cowden D; Pelletier R; Ferguson R; Nadasdy T Hum Pathol; 2005 Nov; 36(11):1178-85. PubMed ID: 16260271 [TBL] [Abstract][Full Text] [Related]
35. C4d deposition in allograft renal biopsies is an independent risk factor for graft failure. Wang R; Wang H; Chen J; Wu J; Wang Y; Huang H; He Q Nephrology (Carlton); 2009 Aug; 14(5):527-32. PubMed ID: 19674321 [TBL] [Abstract][Full Text] [Related]
36. Prevalence and immunohistochemical findings of subclinical kidney allograft rejection and its association with graft outcome. Veronese FV; Noronha IL; Manfro RC; Edelweiss MI; Goldberg J; Gonçalves LF Clin Transplant; 2004 Aug; 18(4):357-64. PubMed ID: 15233810 [TBL] [Abstract][Full Text] [Related]
37. The expression of B-cell activating factor belonging to tumor necrosis factor superfamily (BAFF) significantly correlated with C4D in kidney allograft rejection. Xu H; He X; Sun J; Shi D; Zhu Y; Zhang X Transplant Proc; 2009; 41(1):112-6. PubMed ID: 19249491 [TBL] [Abstract][Full Text] [Related]
38. Correlative insights into the immunoexpression of transforming growth factor beta-1 in acutely rejected renal allografts. Danilewicz M; Wagrowska-Danilewicz M Pathol Res Pract; 2006; 202(1):9-15. PubMed ID: 16343799 [TBL] [Abstract][Full Text] [Related]
39. Analysis of different staining techniques for c4d detection in renal allograft biopsies. Ludovico-Martins H; Silva C; Teodoro WR; Martini Filho D; Noronha IL Transplant Proc; 2009 Apr; 41(3):862-5. PubMed ID: 19376373 [TBL] [Abstract][Full Text] [Related]
40. Estimation of damaged tubular epithelium in renal allografts by determination of vimentin expression. Muramatsu M; Miyagi M; Ishikawa Y; Aikawa A; Mizuiri S; Ohara T; Ishii T; Hasegawa A Int J Urol; 2004 Nov; 11(11):954-62. PubMed ID: 15509197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]